Robotic Prostatectomy and Prostate Cancer-Related Medicaid Spending: Evidence from New York State.

ABSTRACT:

Background

Robotic prostatectomy is a costly new technology, but the costs may be offset by changes in treatment patterns. The net effect of this technology on Medicaid spending has not been assessed.

Objective

To identify the association of the local availability of robotic surgical technology with choice of initial treatment for prostate cancer and total prostate cancer-related treatment costs.

Design and participants

This cohort study used New York State Medicaid data to examine the experience of 9564 Medicaid beneficiaries 40-64 years old who received a prostate biopsy between 2008 and 2017 and were diagnosed with prostate cancer. The local availability of robotic surgical technology was measured as distance from zip code centroids of patient's residence to the ne

SUBMITTER: Ko H 

PROVIDER: S-EPMC8606383 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature